574714 Sigma-AldrichSyk Inhibitor IV, BAY 61-3606 - CAS 732983-37-8 - Calbiochem
Syk Inhibitor IV, BAY 61-3606, CAS 732938-37-8, is a cell-permeable, potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (IC50 = 10 nM).
More>> Syk Inhibitor IV, BAY 61-3606, CAS 732938-37-8, is a cell-permeable, potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (IC50 = 10 nM). Less<<同義語: 2-(7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino)-nicotinamide, HCl, BAY 61-3606
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
732983-37-8 | C₂₀H₁₈N₆O₃ • HCl • H₂O |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
574714-2MGCN |
|
ガラスビン | 2 mg |
|
— |
References | |
---|---|
References | Yamamoto, N., et al. 2003. J. Pharm. Exp. Ther. 306, 1174. |
Product Information | |
---|---|
CAS number | 732983-37-8 |
ATP Competitive | Y |
Form | Yellow solid |
Hill Formula | C₂₀H₁₈N₆O₃ • HCl • H₂O |
Chemical formula | C₂₀H₁₈N₆O₃ • HCl • H₂O |
Hygroscopic | Hygroscopic |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Biological Information | |
---|---|
Primary Target | Syk |
Primary Target IC<sub>50</sub> | 10 nM |
Purity | ≥97% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
574714-2MGCN | 04055977189698 |
Documentation
Syk Inhibitor IV, BAY 61-3606 - CAS 732983-37-8 - Calbiochem (M)SDS
タイトル |
---|
Syk Inhibitor IV, BAY 61-3606 - CAS 732983-37-8 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
574714 |
参考資料
参考資料の概要 |
---|
Yamamoto, N., et al. 2003. J. Pharm. Exp. Ther. 306, 1174. |